breast cancer
Showing NaN - NaN of 241
Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)
Recruiting
- Breast Cancer
- Cyclophosphamide
- +2 more
-
Chicago, IllinoisUniversity of Illinois
Oct 18, 2023
Breast Cancer Trial in Chicago (MOve-ABC, Enhanced Usual Care)
Not yet recruiting
- Breast Cancer
- MOve-ABC
- Enhanced Usual Care
-
Chicago, IllinoisNorthwestern University
Oct 9, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)
Recruiting
- Metastatic Breast Cancer
- +2 more
- Samuraciclib
- Elacestrant Dihydrochloride
-
Orange City, Florida
- +27 more
Jul 19, 2023
Breast Cancer Trial in Chicago (Core Intervention, E-Coach, Buddy)
Not yet recruiting
- Breast Cancer
- Core Intervention
- +4 more
-
Chicago, IllinoisNorthwestern University
Jul 6, 2023
Autologous Fat Grafting in Radiated Soft Tissue Reconstruction
Enrolling by invitation
- Breast Cancer
- +2 more
-
Chicago, IllinoisSummer E Hanson
May 25, 2023
Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)
Completed
- Breast Cancer
- Stage IV Breast Cancer
- palliative surgery
- +3 more
-
Mobile, Alabama
- +376 more
Jan 6, 2023
Breast Cancer Trial in United States (ARV-471, ARV-471 in combination with palbociclib (IBRANCE®))
Recruiting
- Breast Cancer
- ARV-471
- ARV-471 in combination with palbociclib (IBRANCE®)
-
Palo Alto, California
- +16 more
Jan 30, 2023
Breast Cancer, Arthralgia, Pain, Chronic Trial in Chicago, Durham (Online Pain Coping Skills Training, Education)
Recruiting
- Breast Cancer
- +2 more
- Online Pain Coping Skills Training
- Education
-
Chicago, Illinois
- +1 more
Jan 19, 2023
Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)
Active, not recruiting
- Breast Cancer
- trastuzumab
- trastuzumab emtansine
-
Anchorage, Alaska
- +275 more
Dec 13, 2022
Breast Tumors, Breast Diseases, Breast Fibroadenoma Trial in Chicago (Abbreviated MRI protocol: initial experience with Dotarem®
Recruiting
- Breast Neoplasms
- +3 more
- Abbreviated MRI protocol: initial experience with Dotarem® (Gadoterate Meglumine)
-
Chicago, IllinoisUniversity of Chicago Medicine
Dec 21, 2022
Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)
Completed
- Carcinoma, Ductal, Breast
- +6 more
-
Beverly Hills, California
- +14 more
Dec 14, 2022
Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)
Recruiting
- Breast Cancer
- MammaPrint, BluePrint, and Full-Genome Testing
-
Birmingham, Alabama
- +117 more
Dec 1, 2022
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Breast Cancer Trial in United States (Photon, Proton)
Recruiting
- Breast Cancer
- Photon
- Proton
-
Birmingham, Alabama
- +40 more
Nov 18, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)
Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics
Recruiting
- Gastrointestinal Cancer
- +4 more
- Availability of clinical decision support based on pharmacogenomic results.
-
Chicago, IllinoisUniversity of Chicago Medical Center
Oct 20, 2022
Breast Cancer, BRCA Mutation Trial in Chicago (Tranexamic acid, Normal saline)
Recruiting
- Breast Cancer
- BRCA Mutation
- Tranexamic acid
- Normal saline
-
Chicago, Illinois
- +1 more
Sep 21, 2022
Breast Cancer Trial in Chicago (Acupuncture)
Active, not recruiting
- Breast Cancer
- Acupuncture
-
Chicago, IllinoisUniversity of Illinois at Chicago College of Nursing
Sep 18, 2022
Breast Cancer Trial in United States (gemcitabine HCl, imatinib mesylate)
Terminated
- Breast Cancer
- gemcitabine hydrochloride
- imatinib mesylate
-
Chicago, Illinois
- +8 more
Aug 12, 2022